HMC vs MXCT
HMC (HMC) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
HMC (HMC) common stock.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
HMC does not have a complete income-statement cache yet.
Latest reported MXCT revenue for 2026-06-30 was $16.9M. Net income was -$13.6M. Revenue was up 75.3% from 2026-03-31 to 2026-06-30. MXCT currently screens at market cap $124.3M.
HMC currently screens at market cap $0. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the HMC and MXCT stock pages for the full models.
Not investment advice.